Navigation Links
Argonne researcher studies what makes quantum dots blink
Date:10/5/2007

In order to learn more about the origins of quantum dot blinking, researchers from the U.S. Department of Energy's Argonne National Laboratory, the University of Chicago and the California Institute of Technology have developed a method to characterize it on faster time scales than have previously been accessed.

Nanocrystals of semiconductor material, also known as quantum dots, are being intensively investigated for applications such as light-emitting diodes, solid-state lighting, lasers, and solar cells. They are also already being applied as fluorescent labels for biological imaging, providing several advantages over the molecular dyes typically used, including a wider range of emitted colors and much greater stability.

Quantum dots have great promise as light-emitting materials, because the wavelength, or color, of light that the quantum dots give off can be very widely tuned simply by changing the size of the nanoparticles. If a single dot is observed under a microscope, it can be seen to randomly switch between bright and dark states. This flickering, or blinking, behavior has been widely studied, and it has been found that a single dot can blink off for times that can vary between microseconds and several minutes. The causes of the blinking, though, remain the subject of intense study.

The methods developed by Matt Pelton of Argonne's Center for Nanoscale Materials and his team of collaborators has revealed a previously unobserved change in the blinking behavior on time scales less than a few microseconds. This observation is consistent with the predictions of a model for quantum-dot blinking previously developed by Nobel Laureate Rudolph Marcus, contributor to this research, and his co-workers. In this model, the blinking is controlled by the random fluctuation of energy levels in the quantum dot relative to the energies of trap states on the surface of the nanocrystal or in the nearby environment.

The results of
'/>"/>

Contact: Sylvia Carson
scarson@anl.gov
630-252-5510
DOE/Argonne National Laboratory
Source:Eurekalert

Page: 1 2

Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. Tapping hidden assets: Wisconsin researchers who can create jobs
3. Genomics researcher Hood joins NimbleGen board
4. Researcher wants to commercialize adult stem cell discovery
5. National Academies induct five UW researchers
6. Wisconsin researchers defend stem cell company
7. Departure of nanotech researcher stings UW
8. Medical College researcher working to make genetic-based medicine a reality
9. NimbleGen partners with leading researchers
10. Medical College researchers win federal grants
11. Researchers say scientific reporting needs more perspective, less hype
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Pa. , July 28, 2015 ... and Drug Administration has accepted for review the company,s ... factor VIII single-chain (rVIII-SingleChain) for the treatment of hemophilia ... primary endpoints. Hemophilia A ... defective factor VIII; nearly all affected patients are male. ...
(Date:7/27/2015)...  Amgen (NASDAQ: AMGN ) today announced that ... Thursday, July 30, 2015, after the close of the ... a conference call with the investment community at 2 ... be Robert A. Bradway , chairman and chief ... team. Live audio of the conference call ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... today announced a new video: 3 Ways to GHS Labels . This ... and the Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With ...
(Date:7/27/2015)... 27, 2015 The Brain & ... of its annual Klerman and Freedman Prizes, recognizing ... have been supported by NARSAD Young Investigator Grants. ... innovative ideas in neurobiological and psychosocial research, garner ... the early detection, treatment, prevention and cure of ...
Breaking Biology Technology:U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Brady Releases “3 Roads to GHS Labels” Video 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6
... Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ... present a corporate overview of the Company at BioFinance ... The conference will be held at the Toronto Marriott ... the leading investor conference in Canada for the life ...
... Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) ... investigational product candidate, Acetavance(TM) (intravenous acetaminophen), will be presented ... Medicine (ASRA) 34th Annual Regional Anesthesia Meeting in Phoenix, ... of Hospital Medicine (SHM) Annual Meeting in Chicago, Illinois ...
... skin cells to combat aging and help support healing , ... ... Histogen Aesthetics , a division of Histogen focused on providing unique, ... the launch of the ReGenica™ Rejuvenation System for anti-aging and post-resurfacing. ...
Cached Biology Technology:Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioFinance 2009 2Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences 2Histogen Aesthetics Launches ReGenica Rejuvenation System 2Histogen Aesthetics Launches ReGenica Rejuvenation System 3Histogen Aesthetics Launches ReGenica Rejuvenation System 4
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 30, 2015 after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced a new Match-in-Sensor™ ... hardware encapsulated fingerprint sensor and matching solution. ... literally off the grid, isolating fingerprint image ... the fingerprint sensor to provide ultimate protection ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... (Land-use intensity and Ecological Engineering Assessment ... based production systems) is organizing a conference, entitled ... which will be held in Banaue, The Philippines ... 21 research institutions from Germany, Vietnam, The Philippines, ...
... Germany: The first report of the diagnostic use of the ... analysed, shows that it can give good results at low cost, ... of the European Society of Human Genetics today (Monday). ... around 20% of 100 cases of patients with intellectual disability (ID) ...
... Nature Medicine shows that boosting a protein ... from otherwise fatal radiation poisoning. Scientists in the ... June 24 say their findings open the potential ... or environmental exposures such as in a nuclear ...
Cached Biology News:Exome sequencing gives cheaper, faster diagnosis in heterogeneous disease 2Exome sequencing gives cheaper, faster diagnosis in heterogeneous disease 3Boosting blood system protein complex protects against radiation toxicity 2Boosting blood system protein complex protects against radiation toxicity 3
... a cocktail of 3 siRNAs specifically targeted ... most popular product. The siTrio reagent guarantees ... your target gene when used under standard ... confirmation of optimal transfection with one of ...
... 25-Hydroxy Vitamin D kit is an ... of 25-hydroxyvitamin D (25-OH D) and ... or plasma. Our patented DIRECT assay ... precipitation and centrifugation and therefore facilitates ...
... The IDS EIA kit is a complete ... Vitamin D (1,25D) in human serum or ... immunoextraction system found in the IDS 1,25D ... The assay comes with ready to use ...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Biology Products: